Teriparatide biosimilar (Yifan Pharma ）
特立帕肽生物类似药（亿帆医药）
Report date: 2026/05/13 14:53:00
Base Information
Drug NameTeriparatide biosimilar (Yifan Pharma ）
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYifan Pharmaceutical (Shanghai) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesYifan Pharmaceutical (Shanghai) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A